Rossari Biotech Ltd · NSE:ROSSARI

Rossari Biotech — Q4 FY22 Earnings Presentation

21 slides from Rossari Biotech's earnings presentation, May 20, 2022

  1. Slide 1: Exchange filing cover letter for Q4 FY22 earnings presentation

    llij ROSSARI making you more competitive May 20, 2022 DCS-CRD Listing Compliance BSE Limited National Stock Exchange oflndia Ltd. First Floor, New Trade Wing Exchange Plaza, 5th Floor Rotunda Building, Phiroze Jeejeebhoy Towers Plot No.C/1, 'G'Block, Bandra- Kurla Complex Dalal Street, Fort Mumbai 4

  2. Slide 2: Rossari Biotech Limited Q4 & FY22 Results Presentation

    ® ROSSARI making you mor,e comp,etitive Rossari Biotech Limited Q4 & FY22 Results Presentation May 19, 2022

  3. Slide 3: Disclaimer

    ® Disclaimer ROSSARI making you more competitive Certain statements and opinions with respect to the anticipated future performance of Rossari Biotech Ltd (Rossari) in the presentation (“forward-looking statements”), which reflect various assumptions concerning the strategies, objectives and anticip

  4. Slide 4: Q4 & FY22 Results Overview

    ROSSARI making you more competi tive Q4 & FY22 Results Overview 3

  5. Slide 5: Q4 FY22 – Key Financial Highlights

    Q4 FY22 – Key Financial Highlights ® ROSSARI making you more competitive Revenue from Operations EBITDA PAT (Rs. crore) (Rs. crore) (Rs. crore) 24.1 52.3 428.4 438.9 47.9 22.8 22.2 36.0 218.2 Q3 FY22 Q4 FY21 Q4 FY22 Q3 FY22 Q4 FY21 Q4 FY22 Q3 FY22 Q4 FY21 Q4 FY22 Shift % (Y-o-Y) 101% 45% 8% Shift %

  6. Slide 6: FY22 – Key Financial Highlights

    FY22 – Key Financial Highlights ® ROSSARI making you more competitive Revenue from Operations EBITDA PAT (Rs. crore) (Rs. crore) (Rs. crore) 97.7 80.0 183.4 1482.9 124.0 709.3 FY21 FY22 FY21 FY22 FY21 FY22 Shift % (Y-o-Y) 109% 49% 22% Margins (%) 17.5% 12.5% 11.3% 6.6% Note: 1) All figures, unless m

  7. Slide 7: Management Message

    Management Message ROSSARI making you more competitive Commenting on the performance, in a joint statement, Mr. Edward Menezes, Promoter & Executive Chairman, and Mr. Sunil Chari, Promoter & Managing Director, said “We are happy to share that we have closed the year on an encouraging note, despite m

  8. Slide 8: Key Developments

    Key Developments ® ROSSARI making you more competitive Successful conclusion of acquisition and integration of Unitop, Tristar, and Romakk Chemicals in FY2022 • All three companies have delivered encouraging performance during the year on the back of healthy demand and volume offtake in the markets

  9. Slide 9: Key Developments

    Key Developments ® ROSSARI making you more competitive Recent acquisitions augment Rossari’s innovation and technological capabilities • Integration of Unitop, Tristar, and Romakk Chemicals has notably enhanced Rossari’s technical capacity in two key chemistries, namely surfactants and silicones • P

  10. Slide 10: Key Developments

    Key Developments ® ROSSARI o In sync with its strategy to introduce Green Chemistries, Rossari’s R&D has successfully introduced green products in newer segments to reduce high TDS and save energy by designing products that work at lower temperatures. The state-of-the-art 'Sustainable dyeing’, progr

  11. Slide 11: Key Developments

    Key Developments ® ROSSARI making you more competitive Announces annual dividend of Re. 0.50/- per share • For FY 2021-22, the Board of Directors recommended a dividend of Re. 0.50 /- per share • For details on dividend distribution policy, please refer to the Company’s website at Rossari - Dividend

  12. Slide 12: Abridged P&L Statement - Consolidated

    Abridged P&L Statement - Consolidated ® ROSSARI making you more competitive Y-o-Y Change Y-o-Y Change Particulars (Rs. crore) Q4 FY22 Q4 FY21 FY22 FY21 (%) (%) Revenues from Operations 438.9 218.2 101% 1,482.9 709.3 109% Total Expenditure • COGS 324.4 150.6 115% 1,105.0 462.2 139% • Employee benefit

  13. Slide 13: Consolidated Balance Sheet

    Consolidated Balance Sheet ROSSARI making you more competitive EQUITY AND LIABILITIES CONSOLIDATED CONSOLIDATED ASSETS CONSOLIDATED CONSOLIDATED As on 31st March 2022 As on 31st March 2021 As on 31st March 2022 As on 31st March 2021 Particulars (Rs. crore) Particulars (Rs. crore) (Audited) (Audited)

  14. Slide 14: Consolidated Cash Flows

    ® Consolidated Cash Flows ROSSARI CASH FLOW CONSOLIDATED CONSOLIDATED CASH FLOW CONSOLIDATED CONSOLIDATED As on 31st March As on 31st March As on 31st March 2022 As on 31st March 2021 Particulars (Rs. crore) Particulars (Rs. crore) 2022 (Audited) 2021 (Audited) (Audited) (Audited) Cash flows from op

  15. Slide 15: Q4 FY22 - Segment-wise Details

    Q4 FY22 - Segment-wise Details ® ROSSARI making you more competitive Segment-wise Revenue Break-up (Rs. crore) ■ Q4 FY21 ■ Q3 FY22 ■ Q4 FY22 294.0 303.6 108.5 110.6 109.8 87.9 21.8 23.8 25.5 HPPC TSC AHN Shift (Y-o-Y) % 180% 25% 17% Shift (Q-o-Q) % 3% -0.1% 7% Note: 1) All figures, unless mentioned

  16. Slide 16: FY22 - Segment-wise Details

    FY22 - Segment-wise Details ® ROSSARI making you more competitive Segment-wise Revenue Break-up (Rs. crore) ■ FY21 ■ FY22 966.1 399.4 404.7 251.6 112.1 58.3 HPPC TSC AHN Shift (Y-o-Y) % 142% 61% 54% Note: 1) All figures, unless mentioned otherwise, are on a consolidated basis 2) Home, Personal Care

  17. Slide 17: Q4 FY22 - Financial and Operational Discussions (Y-o-Y)

    Q4 FY22 - Financial and Operational Discussions (Y-o-Y) ® ROSSARI making you more competitive Net Revenues Q4 FY22 Revenues from operations stood at Rs. 438.9 crore, higher by 101% YoY; FY22 Revenues from operations up 109% YoY to Rs. 1,482.9 crore  Steady demand and offtake resulted in healthy gro

  18. Slide 18: Annexure

    ROSSARI making you more competitive Annexure 17

  19. Slide 19: Conference Call Details

    ® Conference Call Details ROSSARI making you more competitive ,, ,, ---------------------------------------------------------------- -,, , , ,, '' '' I '' Q4 & FY22 Earnings Conference Call I \ I I I Time • 6:00 p.m. IST on Monday, May 23, 2022 To enable participants to connect to the conference cal

  20. Slide 20: About Us

    ® About Us ROSSARI making you more competitive Rossari Biotech Limited (Rossari) (BSE: 543213, NSE: ROSSARI), is a For further information, please contact: Speciality-Chemicals manufacturer providing intelligent and sustainable solutions for customers across industries. Headquartered at Mumbai, Indi

  21. Slide 21: Thank You

    ® ROSSARI making you more competitive Thanky•u 20

Rossari Biotech — Q4 FY22 Earnings Presentation on 6ix